These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33147100)

  • 1. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.
    Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
    J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal Inhalation Flow Pattern from Turbuhaler Predicted by Laser Photometry.
    Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):139-145. PubMed ID: 34637629
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler.
    Kondo T; Tanigaki T; Yokoyama H; Hibino M; Tajiri S; Akazawa K; Yamada Y; Cassan SM
    J Asthma; 2017 Oct; 54(8):792-797. PubMed ID: 27929704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
    Tajiri S; Kondo T; Tanigaki T; Hibino M; Asano K
    Respir Med; 2022 Sep; 201():106950. PubMed ID: 35963030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
    Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
    Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
    Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
    Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
    Broeders ME; Molema J; Burnell PK; Folgering HT
    J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers.
    Tajiri S; Kondo T; Tanigaki T; Asano K; Hibino M; Horiuchi S; Kobayashi I; Nishiya K
    Tokai J Exp Clin Med; 2020 Sep; 45(3):102-107. PubMed ID: 32901895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.
    Abadelah M; Chrystyn H; Larhrib H
    Eur J Pharm Sci; 2019 Jun; 134():138-144. PubMed ID: 31005623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
    Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IS IT NECESSARY TO PROHIBIT SIDE-HOLE CLOSURE IN USE OF THE DRY POWDER INHALERS?].
    Kondo T; Tanigaki T; Hibino M; Tajiri S; Horiuchi S; Fukuda M; Ohbayashi H
    Arerugi; 2019; 68(2):96-100. PubMed ID: 30867367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.
    Abadelah M; Al-Assadi J; Rooney J; Larhrib H
    Saudi Pharm J; 2020 Jan; 28(1):74-86. PubMed ID: 31920434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
    Al-Showair RA; Tarsin WY; Assi KH; Pearson SB; Chrystyn H
    Respir Med; 2007 Nov; 101(11):2395-401. PubMed ID: 17629471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-Time Particle Emission Monitoring for the Non-Invasive Prediction of Lung Deposition via a Dry Powder Inhaler.
    Hatazoe S; Hira D; Kondo T; Ueshima S; Okano T; Hamada S; Sato S; Terada T; Kakumoto M
    AAPS PharmSciTech; 2024 May; 25(5):109. PubMed ID: 38730125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume.
    Haikarainen J; Vahteristo M; Lähelmä S; Vartiainen V; Malmberg LP
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):305-313. PubMed ID: 32423277
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical problems with aerosol therapy in COPD.
    Rau JL
    Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhalation immediately before inhalation optimizes dry powder inhaler use.
    Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
    J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.